KPC Pharmaceuticals,Inc. (SHA:600422)
China
· Delayed Price · Currency is CNY 15.50
+0.09 (0.58%)
Jun 6, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Wholesale and Retail of Medicines and Equipment | 3.32B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wholesale and Retail of Medicines and Equipment Growth | -7.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular and Cerebrovascular Treatment Areas | 2.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular and Cerebrovascular Treatment Areas Growth | 13.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive System | 535.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive System Growth | -6.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gynecology | 332.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gynecology Growth | 20.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedics Series | 218.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedics Series Growth | -7.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 163.27M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | -70.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-malaria | 91.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-malaria Growth | -18.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 962.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 5.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commodity | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commodity Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-infection | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-infection Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Liver Qi Stagnation | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Liver Qi Stagnation Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Food Production | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 7.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 0.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abroad | 116.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abroad Growth | -22.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong | 9.51M |
Log In |
Log In |
Log In |
Log In | Upgrade
|